SCHEMBL21067334

SCHEMBL21067334

CCc1ccsc1-c1ccc(O)c(O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 3/20 0.43
TRPA1 O75762 1/20 0.41
SNCA P37840 4/20 0.41
MAPT P10636 2/20 0.41
QDPR P09417 2/20 0.41
ESR2 Q92731 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
RECQL P46063 1/20 0.39
HSD17B1 P14061 1/20 0.39
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9773323 0.74 CES1 (0.40) MAPTALDH1A1POLBGAATP53
SCHEMBL2120265 0.73 TP53 (0.42) MAPTALDH1A1GAATP53ALOX15
SCHEMBL15695234 0.69 KMT2A (0.50) MAPTKDM4EALDH1A1GAAHPGD
SCHEMBL15695236 0.68 TP53 (0.49) MAPTKDM4EALDH1A1GAAHPGD
SCHEMBL28149290 0.68 APP (0.64) APPTRPA1MAPTHSD17B1ALOX5
SCHEMBL16049288 0.67 PTGS1 (0.46) MAPTALDH1A1POLBGAAHPGD
SCHEMBL3953461 0.66 HSD17B1 (0.71) APPTRPA1ESR2HSD17B1ALOX5
SCHEMBL16528083 0.66 HSD17B1 (0.50) APPMAPTESR2POLBHSD17B1
SCHEMBL4751712 0.66
SCHEMBL19386812 0.66 TRPA1 (0.68) APPTRPA1QDPRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed